184 related articles for article (PubMed ID: 34287090)
1. PPAR
Mandala A; Chen WJ; Armstrong A; Malhotra MR; Chavalmane S; McCommis KS; Chen A; Carpenter D; Biswas P; Gnana-Prakasam JP
Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G262-G269. PubMed ID: 34287090
[TBL] [Abstract][Full Text] [Related]
2. Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
Cheng R; Ding L; He X; Takahashi Y; Ma JX
Diabetes; 2016 Dec; 65(12):3730-3743. PubMed ID: 27543085
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy.
Yoo J; Jeong IK; Ahn KJ; Chung HY; Hwang YC
Metabolism; 2021 Jul; 120():154798. PubMed ID: 33984335
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
[TBL] [Abstract][Full Text] [Related]
7. Sirt3 inhibits cerebral ischemia-reperfusion injury through normalizing Wnt/β-catenin pathway and blocking mitochondrial fission.
Zhao H; Luo Y; Chen L; Zhang Z; Shen C; Li Y; Xu R
Cell Stress Chaperones; 2018 Sep; 23(5):1079-1092. PubMed ID: 29862442
[TBL] [Abstract][Full Text] [Related]
8. PPARα activation protects against cholestatic liver injury.
Zhao Q; Yang R; Wang J; Hu DD; Li F
Sci Rep; 2017 Aug; 7(1):9967. PubMed ID: 28855630
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate reverses liver fibrosis in cholestatic mice induced by alpha-naphthylisothiocyanate.
Lu Z; Li S; Luo J; Luo Y; Dai M; Zheng X; Qiu J; Yang J; Liu A
Pharmazie; 2021 Feb; 76(2):103-108. PubMed ID: 33714287
[TBL] [Abstract][Full Text] [Related]
10. Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice.
Ernst MC; Sinal CJ; Pollak PT
Pharmacol Res; 2010 Nov; 62(5):408-15. PubMed ID: 20654716
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate prevents iron induced activation of canonical Wnt/β-catenin and oxidative stress signaling in the retina.
Mandala A; Armstrong A; Girresch B; Zhu J; Chilakala A; Chavalmane S; Chaudhary K; Biswas P; Ogilvie J; Gnana-Prakasam JP
NPJ Aging Mech Dis; 2020; 6():12. PubMed ID: 33145027
[TBL] [Abstract][Full Text] [Related]
12. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
13. FGF21 mediates the protective effect of fenofibrate against acetaminophen -induced hepatotoxicity via activating autophagy in mice.
Zhang Y; Pan Y; Xiong R; Zheng J; Li Q; Zhang S; Li X; Pan X; Yang S
Biochem Biophys Res Commun; 2018 Sep; 503(2):474-481. PubMed ID: 29730296
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner.
Chanda D; Lee CH; Kim YH; Noh JR; Kim DK; Park JH; Hwang JH; Lee MR; Jeong KH; Lee IK; Kweon GR; Shong M; Oh GT; Chiang JY; Choi HS
Hepatology; 2009 Sep; 50(3):880-92. PubMed ID: 19593819
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
[TBL] [Abstract][Full Text] [Related]
16. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
17. Chronic activation of PPARα with fenofibrate reduces autophagic proteins in the liver of mice independent of FGF21.
Jo E; Li S; Liang Q; Zhang X; Wang H; Herbert TP; Jenkins TA; Xu A; Ye JM
PLoS One; 2017; 12(4):e0173676. PubMed ID: 28422956
[TBL] [Abstract][Full Text] [Related]
18. PPARα agonist, fenofibrate, ameliorates age-related renal injury.
Kim EN; Lim JH; Kim MY; Kim HW; Park CW; Chang YS; Choi BS
Exp Gerontol; 2016 Aug; 81():42-50. PubMed ID: 27130813
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice.
Kondo K; Sugioka T; Tsukada K; Aizawa M; Takizawa M; Shimizu K; Morimoto M; Suematsu M; Goda N
Adv Exp Med Biol; 2010; 662():77-82. PubMed ID: 20204774
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
